tiprankstipranks
Trending News
More News >
Biodexa Pharmaceuticals (BDRX)
NASDAQ:BDRX
US Market

Biodexa Pharmaceuticals (BDRX) Financial Statements

Compare
529 Followers

Biodexa Pharmaceuticals Financial Overview

Biodexa Pharmaceuticals's market cap is currently $1.43M. The company's EPS TTM is $0; its P/E ratio is -0.04; Biodexa Pharmaceuticals is scheduled to report earnings on September 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue£ 0.00£ 381.00K£ 699.00K£ 578.00K£ 343.00K
Gross Profit£ -5.44M£ -3.69M£ -4.41M£ -4.08M£ -5.72M
Operating Income£ -9.20M£ -8.01M£ -8.93M£ -7.00M£ -23.04M
EBITDA£ -9.08M£ -7.16M£ -8.26M£ -5.66M£ -22.22M
Net Income£ -5.73M£ -7.08M£ -7.66M£ -5.46M£ -22.19M
Balance Sheet
Cash & Short-Term Investments£ 1.67M£ 5.97M£ 2.84M£ 10.06M£ 7.55M
Total Assets£ 14.78M£ 10.54M£ 5.53M£ 12.91M£ 9.82M
Total Debt£ 727.00K£ 464.00K£ 624.00K£ 766.00K£ 260.00K
Net Debt£ -942.00K£ -5.51M£ -2.21M£ -9.29M£ -7.29M
Total Liabilities£ 6.46M£ 5.86M£ 2.36M£ 2.46M£ 3.10M
Stockholders' Equity£ 8.32M£ 4.68M£ 3.16M£ 10.45M£ 6.72M
Cash Flow
Free Cash Flow£ -13.04M£ -7.09M£ -7.11M£ -6.33M£ -9.51M
Operating Cash Flow£ -12.26M£ -6.83M£ -7.05M£ -6.01M£ -9.30M
Investing Cash Flow£ -598.00K£ -265.00K£ -220.00K£ -278.00K£ 2.57M
Financing Cash Flow£ 8.56M£ 10.23M£ 47.00K£ 8.80M£ 3.08M
Currency in GBP

Biodexa Pharmaceuticals Earnings and Revenue History

Biodexa Pharmaceuticals Debt to Assets

Biodexa Pharmaceuticals Cash Flow

Biodexa Pharmaceuticals Forecast EPS vs Actual EPS